Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2.

Komori T. · 2019

Read Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2. by Komori T. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6480215.txt.

Introduction

Komori maps the career of Runx2, the transcription factor without which no bone forms at all: mice lacking it have neither osteoblasts nor mineralized skeleton, and cartilage maturation stalls. Its own expression follows the job, faint in uncommitted mesenchymal cells, peaking in immature osteoblasts, then falling as they mature.

Runx2 pushes progenitor proliferation by directly switching on the Fgf receptors Fgfr2 and Fgfr3, and in skull sutures it recruits hedgehog, Wnt, and parathyroid hormone-related signaling plus the factors Dlx5 and Sp7. Half dosage is not enough there, which is why heterozygous mutation leaves fontanelles open. In vitro, Runx2 drives the major bone matrix genes; its in vivo role in finished osteoblasts remains an open question.

Catalog record

CREATORKomori T.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6480215

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2 By Toshihisa Komori Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms20071694 ABSTRACT Runx2 is essential for osteoblast differentiation and chondrocyte maturation. During osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells, and its expression is upregulated in preosteoblasts, reaches the maximal level in immature osteoblasts, and is down-regulated in mature osteoblasts. Runx2 enhances the proliferation of osteoblast progenitors by directly regulating Fgfr2 and Fgfr3. Runx2 enhances the proliferation of suture mesenchymal cells and induces their commitment into osteoblast lineage cells through the direct regulation of hedgehog (Ihh, Gli1, and Ptch1), Fgf (Fgfr2 and Fgfr3), Wnt (Tcf7, Wnt10b, and Wnt1), and Pthlh (Pthr1) signaling pathway genes, and Dlx5. Runx2 heterozygous mutation causes open fontanelle and sutures because more than half of the Runx2 gene dosage is required for the induction of these genes in suture mesenchymal cells. Runx2 regulates the proliferation of osteoblast progenitors and their differentiation into osteoblasts via reciprocal regulation with hedgehog, Fgf, Wnt, and Pthlh signaling molecules, and transcription factors, including Dlx5 and Sp7. Runx2 induces the expression of major bone matrix protein genes, including Col1a1, Spp1, Ibsp, Bglap2, and Fn1, in vitro. However, the functions of Runx2 in differentiated osteoblasts in the expression of these genes in vivo require further investigation. 1. INTRODUCTION Runx2 belongs to the Runx family, which has the DNA-binding domain runt, and consists of Runx1, Runx2, and Runx3 [1]. Runx2 heterodimerizes with Cbfb and acquires enhanced DNA binding ability and protein stability [2,3,4,5,6]. Runx2 has two promoters, P1 and P2, and the transcript from P1 encodes type II Runx2 and that from P2 encodes type I Runx2. Runx2 is expressed in osteoblasts and chondrocytes. In chondrocytes, Runx2 is weakly expressed in resting chondrocytes and upregulated in prehypertrophic chondrocytes, and this upregulated expression is maintained until terminal hypertrophic chondrocytes [7,8]. Runx2-deficient (Runx2–/–) mice lack osteoblasts and bone formation, and chondrocyte maturation is markedly inhibited [7,9,10,11]. Col2a1, which is expressed in immature chondrocytes, is expressed in whole Runx2–/– skeletons, whereas Col10a1, which is expressed in hypertrophic chondrocytes, is restricted to the tibia, fibula, radius, and ulna. Runx3 is also expressed in chondrocytes, and its expression is upregulated in prehypertrophic chondrocytes and down-regulated in terminal hypertrophic chondrocytes. Runx2–/–Runx3–/– mice lack hypertrophic chondrocytes, suggesting that Runx2 and Runx3 have redundant functions in chondrocyte maturation [12]. Runx2 is expressed in uncommitted mesenchymal cells, and its expression is upregulated in preosteoblasts, reaches the maximum level in immature osteoblasts, and is down-regulated in mature osteoblasts [13,14]. Furthermore, Runx2 regulates the proliferation of osteoblast progenitors, their commitment to osteoblast lineage cells, and the expression of bone matrix protein genes. 2. RECIPROCAL REGULATION OF THE ESSENTIAL TRANSCRIPTION FACTORS FOR OSTEOBLAST DIFFERENTIATION Hedgehog signaling is essential for osteoblast differentiation in endochondral bone. Hedgehog binding to Ptch relieves the repression of Smo, which ultimately regulates Gli [15]. Osteoblasts are absent in Ihh–/– endochondral skeletons and Runx2 expression is absent in the perichondrium [16]. Ihh conditional knockout mice created by crossing with Col2a1 promoter Cre transgenic mice in which Cre is expressed in chondrocytes and perichondrial cells, which are progenitors of osteoblasts, do not form bone. Further, osteoblast marker gene expression, including Runx2, is absent from the perichondrium [17]. In Smo conditional knockout mice created by crossing with Col2a1 Cre transgenic mice, Runx2 expression is only induced outside of the perichondrium where osteoblast progenitors are located, and primary spongiosa is not formed, suggesting that hedgehog signaling is required for Runx2 expression in the perichondrium and Runx2-expressing perichondrial cells are required for primary spongiosa formation [18] (Figure 1). However, the requirement of hedgehog signaling in osteoblast differentiation is transient because the deletion of Smo using Sp7 promoter Cre transgenic mice in which Cre expression begins at the preosteoblast stage does not affect osteoblast differentiation [19]. The sources of osteoblasts in primary spongiosa have been demonstrated to be Sp7-expressing perichondrial cells and the transdifferentiated osteoblasts from hypertrophic chondrocytes [20,21,22]. Runx2 directly regulates Ihh expression in chondrocytes, osteoblast progenitors, and osteoblasts, as well as Gli1 and Ptch1 expression in osteoblast progenitors and osteoblasts [12,14]. Thus, Runx2 and hedgehog signaling regulate each other, and induce osteoblast differentiation (Figure 1). Runx2 directly regulates Sp7 expression, and osteoblasts and bone formation are also absent in Sp7–/– mice [23,24]. As Runx2 is an upstream transcription factor of Sp7, Runx2 is expressed in Sp7–/– mice [24,25]. One major difference between Runx2–/– mice and Sp7–/– mice is the number of mesenchymal cells in the presumptive bone regions. There are abundant mesenchymal cells that express Runx2 in the presumptive bone regions in Sp7–/– mice, whereas there are few in these regions in Runx2–/– mice [25]. This suggests that Runx2 is required for the expansion of mesenchymal cells, as described in detail later. As Sp7 activates an osteoblast-specific enhancer of Runx2, Sp7 is also involved in the regulation of Runx2 expression [26] (Figure 1). Canonical Wnt signaling is also essential for osteoblast differentiation. In conditional Ctnnb1 knockout mice created by crossing with Twist2 (Dermo1) Cre knock-in mice in which Ctnnb1 is deleted in osteo-chondroprogenitors, osteoblasts are absent, Runx2 is expressed in the perichondrial cells, and Sp7 expression is weak or absent in perichondrial cells [27,28]. Conditional Ctnnb1 knockout mice created by crossing with Col2a1 promoter Cre transgenic mice or Prrx1 promoter Cre transgenic mice in which Ctnnb1 is deleted in osteoblast progenitors in calvaria and osteo-chondroprogenitors in limb skeletons also lack osteoblasts in the Cre-expressing skeletons [19,29]. Similar to Sp7–/– mice, conditional Ctnnb1–/– mice also have abundant mesenchymal cells that express Runx2 in the presumptive bone region, suggesting again that Runx2 is required for the expansion of mesenchymal cells. As some of the mesenchymal cells in the perichondrium and calvaria differentiate into chondrocytes in Sp7–/– mice and conditional Ctnnb1–/– mice, Sp7 and canonical Wnt signaling inhibit chondrocyte differentiation and direct Runx2+ osteoblast progenitors to become osteoblasts (Figure 1). 3. REGULATION OF THE PROLIFERATION OF OSTEOBLAST PROGENITORS BY RUNX2 Overexpression of Runx2 under the control of the Prrx1 promoter accelerated osteoblast differentiation, inhibited chondrocyte differentiation, and caused limb defects [30]. The epithelial-mesenchymal interaction loop formed by Fgfs and Fgfrs is essential for limb development. The epithelial-mesenchymal interaction is formed by the different affinities of Fgfs for Fgfr1-3 with the alternatively spliced Ig-like domains of IIIb (“b”) and IIIc (“c”) [31]. Fgf10, which is expressed in the mesenchyme of the limbs, has a high affinity for Fgfr2b in the apical ectodermal ridge (AER), and induces Fgf4 and Fgf8 in the AER. Fgf4 and Fgf8 have a high affinity for Fgfr1c and Fgfr2c, which are expressed in the mesenchyme, and induce the proliferation of the mesenchymal cells. The limb defects in Runx2 transgenic mice were caused by the induction of IIIb isoforms of Fgfr1 and Fgfr2, which have a high affinity for Fgf10, in the mesenchyme, leading to failure of the AER formation and Fgf4 and Fgf8 induction in that region. Consistent with Fgfr1-3 induction in Runx2 transgenic mice, overexpression or knockdown experiments, and reporter and ChIP assays demonstrated that Runx2 directly regulates Fgfr1, Fgfr2, and Fgfr3 [25]. Among Fgfr1-3, the expression levels were Fgfr1>Fgfr2>Fgfr3 in calvarial tissues. Fgfr2 and Fgfr3 play roles in the proliferation of osteoblast progenitors, and they induce proliferation through the mitogen-activated protein

Read the complete text